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Interoffice Memorandum
SCHOOL OF PHARMACY
OFFICE OF THE DEAN
University, MS 38677
Phone: (662) 915-7265 Fax: (662) 915-5704
TO: All School of Pharmacy Personnel
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs
DATE: November 18, 2004
SUBJECT: Research News (#3)
                                                                                                                                                                        
The following GRANTS/CONTRACTS have recently been awarded:
1. Dr. Mitchell Avery (P.I. – Medicinal Chemistry), Dr. John Williamson (Co-P.I. – Medicinal
Chemistry), Dr. John Rimoldi (Co-P.I. – Medicinal Chemistry)  – Development and Testing of New
Medicines for Treatment of Emerging Infectious Diseases (DHHS/Centers for Disease Control and
Prevention), $1,500,000.00 – September 15, 2004-September 14, 2005.
2. Dr. Mitchell Avery (P.I. – Medicinal Chemistry), Dr. John Williamson (Co-P.I. – Medicinal
Chemistry), Dr. John Rimoldi (Co-P.I. – Medicinal Chemistry)  – Development and Testing of New
Antimalarial Drugs (DHHS/Centers for Disease Control and Prevention), $3,000,000.00 – August 1,
2004-July 31, 2005.
3. Dr. Alicia Bouldin (P.I. – Pharmacy Administration) – Toward an Understanding of Personal
Involvement and Intrinsic Motivation to Learn Among Pharmacy Students (American Association of
Colleges of Pharmacy/American Foundation for Pharmaceutical Education New Investigators Program),
$5,307.00 – January 1, 2005-January 1, 2006.
4. Dr. Charles Burandt (P.I. – RIPS/NCNPR) – MAJIC Planning Grant Proposal – Medicinal Plant
Processing Facility and Extraction Site (Mississippi Development Authority), $25,000.00 – July 1,
2004-December 31, 2004.
5. Dr. John Cleary (P.I. – Pharmacy Practice) – Pharmacogenomics of Natural Products with Antifungal
Activity (National Institutes of Health), $313,331.00 – July 1, 2004-June 30, 2005.
6. Dr. John Cleary (P.I. – Pharmacy Practice) – Pharmaceutical Company Support (Pfizer Global
Pharmaceuticals), $1,000.00 – October 20, 2004-December 31, 2004.
7. Dr. Ikhlas Khan (P.I. – RIPS/NCNPR) – Optimizing Therapeutic Ratios of Herbs: Gingko as a Model
(Harvard Medical School/National Institutes of Health), $44,001.00 – July 1, 2004-June 30, 2005 (Sub-
contract).
8. Dr. Ikhlas Khan (P.I. – RIPS/NCNPR) and Dr. Troy Smillie (Co-P.I. – RIPS/NCNPR) – Phytotoxins
from Asian Soybean Rust Phakopsora pachyrhizi (Mississippi State University NSF proposal),
$74,681.00 – October 1, 2004-March 31, 2005.
9. Dr. Ikhlas Khan (P.I. – RIPS/NCNPR) – Mechanisms of Ginkgo Biloba Neuroprotection (The




10. Dr. Larry Walker (P.I. – RIPS/NCNPR) – Development of Natural Products from Plants and Microbes
for Replacement of Synthetic Pesticides (U.S. Dept. of Agriculture), $2,388,211.00 – November 21,
2004-October 31, 2005.
11. Dr. Larry Walker (P.I. – RIPS/NCNPR) and Dr. Ikhlas Khan (Co-P.I. – RIPS/NCNPR) – Botanical
Dietary Supplements: Science-Base for Authentication and Analysis (Food and Drug Administration),
$831,547.00 – September 30, 2004-September 29, 2005.
12. Dr. Larry Walker (P.I. – RIPS/NCNPR) and Dr. Ikhlas Khan (Co-P.I. – RIPS/NCNPR) – Botanical
Dietary Supplements: Science-Base for Authentication and Analysis/Supplemental Funding (Food and
Drug Administration), $493,453.00 – September 30, 2004-September 29, 2005.
13. Dr. Barbara Wells (P.I. – RIPS/School of Pharmacy) and Dr. Charles Huffod (Co-P.I. RIPS/School of
Pharmacy) – National Center for Natural Products Research – Phase II (Dept. of Health and Human
Services Heath Resources and Services Administration), $1,781,329.00 – July 1, 2004-June 30, 2005.
14. Dr. Noel Wilkin (P.I. – Pharmacy Administration) – ESRD Outpatient Medications (Network 8, Inc.),
$198,250.00 – July 1, 2004-June 30, 2005.
15. Dr. Kristie Willett (P.I. – Pharmacology) – Roles of CYP1 & 19 in Fundulus Steroid & PAH
Metabolism (NIH/National Institute of Environmental Health Sciences), $256,913.00 – July 1, 2004-
April 30, 2005.
16. Dr. John Williamson (P.I. – Medicinal Chemistry) – IGERT – Entrepreneurship at the Interface of
Polymer Science and Medicinal Chemistry (The University of Southern Mississippi/National Science
Foundation), $299,760.00 – October 1, 2004-September 30, 2005.
The following PUBLICATIONS have appeared:
1. Hassan Abou-Gazar, E. Bedir, Satoshi Takamatsu, Daneel Ferreira, and Ikhlas Khan –
“Antioxidant lignans from Larrea tridentate”, Phytochemistry, 65 , pp. 2499-2505, 2004.
2. Z.S. Akdemir, Irem Tatli, E. Bedir and Ikhlas Khan – “Antioxidant flavonoids from Verbascum
salviifolium boiss”, FABAD Journal of Pharmaceutical Sciences, 28 , pp. 71-75, 2003.
3. Z.S. Akdemir, Irem Tatli, E. Bedir and Ikhlas Khan – “Iridoid and phenylethanoid glycosides from
Verbascum lasianthum”, Turkish Journal of Chemistry, 28 , pp. 227-234, 2004.
4. Y. Akgul, Daneel Ferreira, E. Abourashed and Ikhlas Khan – “Lotaustralin from Rhodiola rosea
roots”, Fitoterapia, 75 , pp. 612-614, 2004.
5. Mitchell Avery, Larry Walker and N. Peleng – “Preparation of hydroxyarylbenzopyranones and
evaluation as antigiardial agents and uses thereof”, PCT Int. Appl., p. 72, 2004.
6. Bharathi Avula and Ikhlas Khan – “Separation and determination of ephedrine enantiomers and
synephrine by high performance capillary electrophoresis in dietary supplements”, Chromatographia,
59 , pp. 71-77, 2004.
7. S.C. Benson, H.A. Pershadsingh, C.I. Ho, Amar Chittiboyina, Prashant Desai, et al. – “Identification
of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARg-Modulating
Activity”, Hypertension, 43 , pp. 993-1002, 2004.
8. N. Bhagavathula, K.C. Nerusu, A. Lal, C.N. Ellis, Amar Chittiboyina et al. – “Rosiglitazone inhibits
proliferation, motility, and matrix metalloproteinase production in keratinocytes”, Journal of
Investigative Dermatology, 122, pp. 130-139, 2004.
9. Sreekhar Cheboyina, Walt Chambliss and Christy Wyandt – “A Novel Freeze Pelletization
Technique for Preparing Matrix Pellets”, Advanstar Communications, 2003.
10. Amar Chittiboyina, Raji Chada, Blake Watkins and Mitchell Avery – “First synthesis of
antimalarial Machaeriols A and B”, Tetrahedron Letters, 45 , pp. 1689-1691, 2004.
11. Amar Chittiboyina, Raji Chada, Blake Watkins and Mitchell Avery – “Addition of
lithioimidazoles to isocyanates followed by Pd-coupling: access to 4-substituted imidazole-2,5-
dicarboxamides”, Tetrahedron Letters, 45 , pp. 1869-1872, 2004.
12. Robert Doerksen, B. Chen, D. Liu, G.N. Tew, W.F. DeGrado and M.L. Klein – “Controlling the
Conformation of Arylamides: Computational Studies of Intramolecular Hydrogen Bonds Between Amides
and Ethers or Thioethers”, Chemistry: A European Journal, 10 , pp. 5008-5016, 2004.
13. C. Erbel-Sieler, C. Dudley, Yu Dong Zhou, X. Wu, S.J. Estill, T. Han, R. Diaz-Arrastia, E.W. Brunskill,
S.S. Potter and S.L. McKnight – “Behavioral and regulatory abnormalities in mice deficient in the
NPAS1 and NPAS3 transcription factors”, PNAS, 101, pp. 13648-13653, 2004.
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14. M. Ganzera, H. Stuppner and Ikhlas Khan – “Simultaneous determination of saponins and isoflavones
in soybean (Glycine max L.) by reversed-phase liquid chromatography with evaporative light-scattering
and ultraviolet detection”, Journal of AOAC International, 87 , pp. 1189-1194, 2004.
15. M. Ganzera, J. Gampenrieder, Rahul Pawar, Ikhlas Khan, and H. Stuppner – “Separation of the major
triterpenoid saponins in Bacopa monnieri by high-performance liquid chromatography”, Analytica
Chimica Acta, 516, pp. 149-154, 2004.
16. K. Garrett, G. Basmadjian, Ikhlas Khan, B.T. Schaneberg and T.W. Seale – “Extracts of kava (Piper
methysticum) induce acute anxiolytic-like behavioral changes in mice”, Psychopharmacology, 170, pp.
33-41, 2003.
17. Mary Haasch and Annette Ford – “Combined effects of ethanol and cinnamaldehyde in the Japenese
medaka embryo-larval assay (MELA)”, Marine Environmental Research, 58 , pp. 175-179, 2004.
18. G. R. Labadie, Seoung-Ryoung Choi and Mitchell Avery – “Diamine derivatives with antiparasitic
activities”, Bioorganic & Medicinal Chemistry Letters, 14 , pp. 615-619, 2004.
19. M.S. Levi, Omar Khan and Ronald Borne – “Solution-Phase Parallel Synthesis of N-Substituted
Isoquinuclidines”, Letters in Drug Design and Discovery, pp. 384-386, 2004.
20. D. Liu, S. Choi, B. Chen, Robert Doerksen, D.J. Clements, J.D. Winkler, M.L. Klein, W.F. DeGrado –
“Nontoxic Membrane-Active Antimicrobial Arylamide Oligomers”, Angewandte Chemie International
Edition, 43 , pp. 1158-1162, 2004.
21. Guoyi Ma, Shabana Khan, Melissa Jacob, Babu Tekwani, Zuqiang Li, David Pasco, Larry
Walker and Ikhlas Khan – “Antimicrobial and Antileishmanial Activities of Hypocrellins A and B”,
Antimicrobial Agents and Chemotherapy, 48 , pp. 4450-4452, 2004.
22. J.W. McGinity and Michael Repka – “Hot-Melt Extruded Films for Transmucosal and Transdermal
Drug Delivery Applications”, Drug Del Tech, 4, pp. 72-78, 2004.
23. K. McLuskey, F. Gibellini, Paulo Carvalho, Mitchell Avery and W.N. Hunter – “Inhibition of
Leishmania major pteridine reductase by 2,4,6-triaminoquinazoline: structure of the NADPH ternary
complex”, Acta Crystallographica, Section D: Biological Crystallography, 60 , pp. 1780-1785, 2004.
24. E.M.F. Muri, M. Gomes, J.S. Costa, F.L. Alencar, A. Sales, M.L. Bastos, R. Hernandez-Valdes, M.G.
Albuquerque, E.F.F. da Cunha, R.B. Alencastro, John Williamson and Q.A.C. Antunes – “N-t-Boc-
amino acid esters of isomannide Potential inhibitors of serine proteases”, Amino Acids, 27 , pp. 153-159,
2004.
25. E.M.F. Muri, H. Mishra, Steven Stein and John Williamson – “Molecular Modeling, Synthesis and
Biological Evaluation of Heterocyclic Hydroxamic Acids Designed as Helicobacter Pylori Urease
Inhibitors”, Letters in Drug Design & Discovery, pp. 30-34, 2004.
26. E.M.F. Muri, Marcelo Nieto and John Williamson – “Hydroxamic Acids as Pharmacological Agents:
An Upate”, Medicinal Chemistry Reviews – Online, pp. 385-394, 2004.
27. E.M.F. Muri and John Williamson – “Anti-Helicobacter pylori Agents. An Update”, Mini Reviews in
Medicinal Chemistry, 4, pp. 201-206, 2004.
28. J. Mustafa, R. Khan, Ikhlas Khan, and Daneel Ferreira – “Benzylation of flavan-3-ols (catechins)”,
Organic Preparations and Procedures International, 36 , pp. 61-67, 2004.
29. J. Mustafa, Shabana Khan, Guoyi Ma, Larry Walker and Ikhlas Khan – “Synthesis and anticancer
activities of fatty acid analogs of podophyllotoxin”, Lipids, 39 , pp. 167-172, 2004.
30. Igor Parshikov, Kannoth Muraleedharan, Bruhaspathy Miriyala, Mitchell Avery and John
Williamson – “Hydroxylation of 10-Deoxoartemisinin by Cunninghamella elegans”, Journal of
Natural Products, 67 , pp. 1595-1597, 2004.
31. H.A. Pershadsingh and Mitchell Avery – “Novel PPAR agonists, pharmaceutical compositions and uses
thereof”, PCT Int. Appl, p. 100, 2004.
32. Karumanchi Rao, Noer Kasanah, S. Wahyuono, Babu Tekwani, R.F. Schinazi and Mark Hamann
– “Three New Manzamine Alkaloids from a Common Indonesian Sponge and Their Activity Against
Infectious and Tropical Parasitic Diseases”, Journal of Natural Products, 67 , pp. 1314-1318, 2004.
33. Michael Repka, Praveen Mididoddi and Steven Stodghill – “Influence of Human Nail Etching for
the Assessment of Topical Onychomycosis Therapies”, International Journal of Pharmaceutics, 282,
pp. 95-106, 2004.
34. Michael Repka, Suneela Prodduturi, Manish Munjal, and Praveen Mididoddi – “Matrix and
Reservoir-Based Transmucosal Delivery Systems: Tailoring Delivery Solutions”, American J. Drug
Delivery, 2, pp. 173-192, 2004.
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35. B.T. Schaneberg, R. Molyneux and Ikhlas Khan – “Evaporative light scattering detection of
pyrrolizidine alkaloids”, Phytochemical Analysis, 15 , pp. 36-39, 2004.
36. Nurhayat Tabanca, Shabana Khan, E. Bedir, S. Annavarapu, Kristine Willett, Ikhlas Khan, N.
Kirimer and K.H.C. Baser – “Estrogenic Activity of Isolated Compounds and Essential Oils of Pimpinella
Species from Turkey, Evaluated using a Recombinant Yeast Screen”, Planta Medica, 70 , pp. 728-735,
2004.
37. Irem Tatli, Z.S. Akdemir, E. Bedir and Ikhlas Khan – “Saponin, iridoid, phenylethanoid and
monoterpene glycosides from Verbascum pterocalycinum var. mutense”, Turkish Journal of Chemistry,
28 , pp. 111-122, 2004.
38. AK. Tripathi, Prashant Desai, Anupam Pradhan, Shabana Khan, Mitchell Avery, Larry Walker
and Babu Tekwani – “An alpha-proteobacterial type malate dehydrogenase may complement LDH
function in Plasmodium falciparum – Cloning and biochemical characterization of the enzyme”,
European Journal of Biochemistry, 271, pp. 3488-3502, 2004.
39. Francis Tukov, Sridhar Anand, Rama Gadepalli, A.A.L. Gunatilaka, John Matthews and John
Rimoldi – “Inactivation of the Cytotoxic Activity of Repin, a Sesquiterpene Lactone from Centaurea
repens”, Chem. Res. Toxicology, 17 , pp. 1170-1176, 2004.
40. Francis Tukov, John Rimoldi and John Matthews – “Characterization of the Role of Glutathione in
Repin-Induced Mitochondrial Dysfunction, Oxidative Stress and Dopaminergic Neurotoxicity in Rat
Pheochromocytoma (PC12) Cells”, NeuroToxicology, 25 , pp. 989-999, 2004.
41. M.S. Venkatraman, Amar Chittiboyina, J. Meingassner, C.I. Ho, J. Varani. et al. – “A-Lipoic acid-
based PPARg agonists for treating inflammatory skin diseases”, Archives of Dermatological Research,
296, pp. 97-104, 2004.
42. F. Wei, S.C. Ma, L.Y. Ma, P. But, R.C. Lin and Ikhlas Khan – “Antiviral Flavonoids from the Seeds of
Aesculus chinensis”, Journal of Natural Products, 67 , pp. 650-653, 2004.
43. A. Yesilada, S. Koyunoglu, N. Saygili, E. Kupeli, E. Yesilada, E. Bedir and Ikhlas Khan – “Synthesis,
anti-inflammatory and analgesic activity screening of some new 4(3H)-quinazolinone derivatives”,
Archiv der Pharmazie (Weinheim, Germany), 337, pp. 96-104, 2004.
44. Yan-Song Zheng and Mitchell Avery – “Asymmetric aldol reactions using catalytic D-(+)-proline: a
new, economic and practical approach to a commonly employed C1-C6 keto-acid synthon of the
epothilones”, Tetrahedron, 60 , pp. 2091-2095, 2004.
TECHNOLOGY TRANSFER transactions:
In the interest of protecting confidential information, the names and titles associated with School of
Pharmacy invention disclosures and patent applications will no longer be published until after a patent has
issued.
Invention Disclosures Filed in 2004: 10
Patent Applications Pending: 29
Recent Patents Granted:  1
“Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents”
US Patent #: 6,790,863
Mahmoud A. ElSohly, Samir A. Ross, Ahmed M. Galal
September 14, 2001
The following SPECIAL ANNOUNCEMENTS are also listed:
• The research of Robert J. Doerksen (Medicinal Chemistry and RIPS) on computational approaches
to effective and selective antimicrobial oligomers was featured recently in the Society Journal of the
American Society for Microbiology (July 2004) and in Business Week (April 19, 2004).
• The American Association of Pharmaceutical Scientists Annual Southern Regional Meeting (AAPS
SRDG) was held May 17-18, 2004 at the University of Tennessee Health Science Center, Memphis,
TN.  The following Podium and Poster presentations were presented:
Podium Presentation:  Suneela Prodduturi, Melissa Jacob, Steven Stodghill, Michael Repka
– “Characterization of hot-melt extruded films containing antifungals for oral candidiasis”.
Poster Presentations:  (1) Praveen Mididoddi, Steven Stodghill, Michael Repka – “Influence
of 'etching' on the permeability of ketoconazole through the human nail”, (2) Sreekhar
Cheboyina, Christy Wyandt – “Evaluation of the effect of drug solubility on the characteristics
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of matrix pellets prepared by the freeze pelletization technique”. (3) Amit Shah, John
Williamson, Christy Wyandt – “Pre-formulation studies of a novel anti-tumor agent”.
Pharmaceutics graduate students received the following awards for their exceptional presentations:
Suneela Prodduturi – Outstanding Podium Presentation award; Praveen Mididoddi –
Outstanding Poster Presentation award.
The next AAPS SRDG Annual meeting will be held here at Ole Miss in May 2005.
• The following presentation was made during the American Association of Pharmaceutical Scientists
(AAPS) Meeting in Baltimore, MD, November 2004:  Amit Shah, John Williamson, Steven
Stodghill and Christy Wyandt – “Characterization of novel tubulin binding agent and its
comparison with taxol”.
• John Williamson participated in the Special Emphasis Panel, National Cooperative Drug
Discovery Groups for Cancer (NCDDG) Chemistry/Natural Products Review Panel, National Cancer
Institute, National Institutes of Health, Gaithersburg, MD October 27-29, 2004.
• Dr. Williamson has also been invited to participate in: (a) Special Emphasis Panel, United States
Department of Agriculture, Cooperative State Research, Education, and Extension Service, Small
Business Innovation Research Program (SBIR), Rural & Community Development, January 2005;
and  (b) Special Emphasis Panel, the Integrative Graduate Education and Research Traineeship
(IGERT) program, National Science Foundation (NSF), Arlington, VA January 27-28, 2005.
Please continue to send me important research and graduate information so that I might share it with your
faculty colleagues.  THIS INFORMATION IS NOW BEING POSTED ON THE SCHOOL OF
PHARMACY WEB PAGE!  Thank you.
cc: Dean Barbara G. Wells
Ms. Dabney Weems
